Intensity modulation techniques for spinal treatments and on-line VolumeView TM guidance

Similar documents
MOSAIQ TM Image Enabled EMR. managing the spectrum of cancer care. Filmless and paperless workflow Universitätsklinikum Mannheim

Elekta Infinity. Digital accelerator for advanced treatments. Redefining treatment precision, speed and control

Elekta Synergy Digital accelerator for advanced IGRT

Educational workshop: Real-time Image-Guided HDR Brachytherapy for Prostate Cancer

Elekta Infinity Digital accelerator for advanced treatments

Clinical Workshop. HDR and electronic. brachytherapy for skin cancer

brachytherapy Medical University of Vienna, Vienna, Austria, November 2014 Educational Workshop 3-D image-guided adaptive

Educational workshop: Brachytherapy for Gynecology Using MRI-based Intracavitary Technique

Technical Study. Institution University of Texas Health San Antonio. Location San Antonio, Texas. Medical Staff. Daniel Saenz. Niko Papanikolaou.

Quality assurance and credentialing requirements for sites using inverse planned IMRT Techniques

Staged-Volume Radiosurgery of Large AVMs

IROC Lung Phantom 3D CRT / IMRT. Guidelines for Planning and Irradiating the IROC Lung Phantom. Revised Dec 2015

Lung Spine Phantom. Guidelines for Planning and Irradiating the IROC Spine Phantom. MARCH 2014

Quality assurance of volumetric modulated arc therapy using Elekta Synergy

Activity report from JCOG physics group

IROC Head and Neck Phantom. Guidelines for Planning and Irradiating the IROC IMRT Phantom. Revised MARCH 2014

IROC Liver Phantom. Guidelines for Planning and Irradiating the IROC Liver Phantom. Revised July 2015

A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse

Evaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases

IMRT QUESTIONNAIRE. Address: Physicist: Research Associate: Dosimetrist: Responsible Radiation Oncologist(s)

VMAT plans for treatment prostate cancer: Dosimetric verifications and comparison with 3D-CRT and IMRT

Treatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI)

A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *

Case Study. Institution Farrer Park Hospital

Original Article. Teyyiba Kanwal, Muhammad Khalid, Syed Ijaz Hussain Shah, Khawar Nadeem

IROC Head and Neck Phantom. Guidelines for Planning and Irradiating the IROC IMRT Phantom. Revised April 2014

Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO

Reena Phurailatpam. Intensity Modulated Radiation Therapy of Medulloblastoma using Helical TomoTherapy: Initial Experience from planning to delivery

Variable Dose Rate Dynamic Conformal Arc Therapy (DCAT) for SABR Lung: From static fields to dynamic arcs using Monaco 5.10

Verification of treatment planning system parameters in tomotherapy using EBT Radiochromic Film

IROC Prostate Phantom. Guidelines for Planning and Treating the IROC IMRT Prostate Phantom. Revised March 2014

A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer

VARIAN ONCOLOGY. RapidArc. One revolution is all it takes.

Online Care, Online Control, Online Confidence

Prostate Phantom. Guidelines for Planning and Treating the IMRT Prostate Phantom. Revised March 2014

Assessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom

TOMOTERAPIA in Italia: Esperienze a confronto

IMAT: intensity-modulated arc therapy

Venezia Advanced Gynecological Applicator Reaching beyond

BREAST CANCER CLINICAL ADVANTAGES

Verification of Advanced Radiotherapy Techniques

A TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM *

Precisely Maximize Dose, side effects, Patient

Treatment Planning & IGRT Credentialing for NRG SBRT Trials

ABAS Atlas-based Autosegmentation

ICRU Report 91 Was ist neu, was ändert sich?

Traceability and absorbed dose standards for small fields, IMRT and helical tomotherapy

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

Defining Target Volumes and Organs at Risk: a common language

Leila E. A. Nichol Royal Surrey County Hospital

WHOLE-BRAIN RADIOTHERAPY WITH SIMULTANEOUS INTEGRATED BOOST TO MULTIPLE BRAIN METASTASES USING VOLUMETRIC MODULATED ARC THERAPY

Dosimetric verification and quality assurance of runningstart-stop (RSS) delivery in tomotherapy

IMRT Planning Basics AAMD Student Webinar

Efficient Dosimetry for Proton Therapy

Elekta - a partner and world-leading supplier

8/2/2018. Disclosure. Online MR-IG-ART Dosimetry and Dose Accumulation

The role of Radiation Oncologist: Hi-tech treatments for liver metastases

Introduction of RapidArc TM : an example of commissioning and implementing a QA programme for a new technology

Chapters from Clinical Oncology

Intensity Modulated Radiation Therapy: Dosimetric Aspects & Commissioning Strategies

Normal tissue dose in pediatric VMAT Piotr Zygmanski

Elekta Innovation and Growth. ESTRO 2012 Capital Markets Presentation

Accuracy Requirements and Uncertainty Considerations in Radiation Therapy

SBRT fundamentals. Outline 8/2/2012. Stereotactic Body Radiation Therapy Quality Assurance Educational Session

The Physics of Oesophageal Cancer Radiotherapy

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment

Spatially Fractionated Radiation Therapy: GRID Sponsored by.decimal Friday, August 22, Pamela Myers, Ph.D.

Intensity modulated radiotherapy (IMRT) for treatment of post-operative high grade glioma in the right parietal region of brain

Evaluation of Three-dimensional Conformal Radiotherapy and Intensity Modulated Radiotherapy Techniques in High-Grade Gliomas

Dosimetric study of 2D ion chamber array matrix for the modern radiotherapy treatment verification

3D Pre-treatment Dose Verification for Stereotactic Body Radiation Therapy Patients

Radiotherapy and Radiosurgery

Additional Questions for Review 2D & 3D

The objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical

Intensity Modulated RadioTherapy

A review of RTTQA audit. Karen Venables

THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS

Clinical Impact of Couch Top and Rails on IMRT and Arc Therapy

Automated Plan Quality Check with Scripting. Rajesh Gutti, Ph.D. Clinical Medical Physicist

Master s science Thesis. Evaluation of gantry angle optimization for IMRT treatment planning systems using the Pareto front approach.

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

3D-CRT Breast Cancer Planning

PRECISE, ROBOTIC TREATMENT AS INDIVIDUAL AS EVERY PATIENT

Utilizzo delle tecniche VMAT nei trattamenti del testa collo Marta Scorsetti M.D.

STEREOTACTIC DOSE VERIFICATION PHANTOM VERSATILE STEREOTACTIC QA PHANTOMS

Guidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy

Dosimetric Analysis Report

Implementation of advanced RT Techniques

Mitsubishi Heavy Industries Technical Review Vol. 51 No. 1 (March 2014)

Clinical Implementation of SRS/SBRT

Advanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark*

Applications of Modern Radiotherapy Systems

160 MLC Multileaf Collimator. The best-in-class collimator available. Fighting cancer fast and focused.

IMRT FOR CRANIOSPINAL IRRADIATION: CHALLENGES AND RESULTS. A. Miller, L. Kasulaitytė Institute of Oncolygy, Vilnius University

RPC Liver Phantom Highly Conformal Stereotactic Body Radiation Therapy

GAMMA DOSE DISTRIBUTION EVALUATION OF XiO TREATMENT PLANNING SYSTEM FOR STATIC FIELD IMRT, USING AAPM TG-119

Future upcoming technologies and what audit needs to address

Advances in external beam radiotherapy

Canadian Partnership for Quality Radiotherapy. Technical Quality Control Guidelines for Gamma Knife Radiosurgery. A guidance document on behalf of:

Transcription:

IMAGE GUIDED RADIATION THERAPY Elekta Synergy Intensity modulation techniques for spinal treatments and on-line VolumeView TM guidance Institution: U.O. Radiobiologia Clinica, Universita Di Firenze Casa Di Cura S. Chiara, Florence Purpose: The use of intensity modulation and in-room image guidance have made the delivery of high doses to lesions in close proximity of the spinal cord feasible. This report presents the physical data concerning the use of intensity modulated arc therapy (IMAT) for hypo-fractionated treatments of spinal and paraspinal tumors. The importance of image guided radiation therapy (IGRT) to ensure the actual delivery of the planned dose distributions is also discussed analyzing the on-line set-up corrections obtained by VolumeView TM volume imaging for these treatments. For the same cases, IMRT step-and-shoot plans are computed and compared with IMAT plans. Accuracy study

Intensity modulation techniques for spinal treatments and on-line VolumeView TM guidance L. Masi, I Bonucci, C Menichelli, C Polli, F Casamassima Methods and materials 16 plans for spinal and paraspinal lesions are investigated: in 14 the PTV was partially wrapped around the cord and the PTV to OAR distance was <2mm in 11 cases. An intensity modulated arc treatment technique was employed, creating two series of overlapping arcs (total 10 to 18 arcs) and adding two to four fixed beams to improve target dose homogeneity. Plans were optimized to meet a maximum cord constraint of 6Gy (to no more than 1% of volume) per fraction, prescribing 9Gy at 90% of the PTV (although PTV coverage was largely dictated by the cord tolerance dose). Plan creation and optimization was performed using Ergo ++ planning system. Plans were delivered in three consecutive fractions. In the majority of cases (12/16) treatment planning and delivery was accomplished using dynamic mmlc (5mm leaf width; for four patients with lesions of increased dimensions, planning was performed in a static arc modality, using Elekta Synergy MLC, leaf width of 1cm). Pre-treatment dosimetric verifications were performed in a solid phantom measuring absolute point doses (A16 Exradin ion chamber) and dose distributions, in a coronal plane including the cord, by film dosimetry (Kodak EDR2: MUs were rescaled for the film linear range). Film to plan comparison was evaluated in terms of γ index (3%, 3mm). Set-up accuracy prior to treatment delivery was ensured by performing on-line corrections guided by Elekta Synergy VolumeView TM at each fraction (48 fractions). Table 1: averaged values and standard deviation of the translation corrections along the three axes on-line corrections for 16 patients (48 fractions). X (mm) Y (mm) Z (mm) Mean 0.2 1.4-2.0 SD 3.3 3.7 2.6

Figure 1: image guidance using VolumeView TM.

For eight patients, IMRT step-and-shoot plans (five to nine coplanar beams, 50 to 93 segments) were optimized (Masterplan Oncentra TM Nucletron) using the same cord constraint and compared with IMAT-AMOA plans in terms of the isodose including 90% of the PTV (D90), conformity index (at D90 and 6Gy), dose homogeneity (ratio of Dmax to D90) and total MUs.

Figure 2: above and left IMAT-AMOA plans for spinal treatments, dose distributions and arc configurations for two of the examined plans.

Results Ion chamber measurements with respect to the treatment planning system calculated dose, show a mean deviation of 1.2% (max. 3.2 %). Analyzing the γ values distributions for plan to film comparison, the percentage of points satisfying γ < 1 for IMAT plans ranges between 87% and 98% (mean 93%). Figure 3: IMAT-AMOA pre-treatment dosimetric verifications, plan to film comparison in a coronal plane including the cord. (left) comparison of calculated (plan) and measured (film) isodoses (below) γ values distribution for the same case. Considering the set-up errors obtained from IGRT for all patients and all fractions, the mean values and related standard deviations are 0.2 (SD= 3.3)mm, 1.4 (SD= 3.7)mm and -2.0 (SD= 2.6)mm, respectively for the lateral (X), longitudinal (Y) and anterior-posterior (Z) displacements. D90 values (per fraction) range from 7.2 to 9.5Gy (mean 8.0Gy) for IMAT-AMOA plans and from 7.8 to 9.5Gy (mean 8.5Gy) for IMRT plans. Averaged conformity index values at D90 and 6Gy are respectively 1.4 and 3.1 for dynamic IMAT and 1.8 and 4.4 for step-and-shoot. The mean values of homogeneity ratio are 1.3 for dynamic arc treatments and 1.6 for IMRT plans. Considering the four static MLC arc plans averaged CI values are 1.9 (D90) and 3.5 (6Gy) and the calculated mean value for the homogeneity ratio is 1.4. Total MUs for step-and-shoot plans are three to four times those delivered with IMAT (both dynamic and static MLC).

IMAT dynamic arc (5mm leaf) eight plans mean range PTV coveraged90 (per fraction) 8.0Gy 7.2 9.5Gy Conformity index (D90) 1.4 1.3 1.6 Conformity Index (6Gy) 3.1 2.3 3.3 Homogeneity Dmax/D90) 1.3 1.2 1.4 IMRT step-and-shoot (10mm leaf) eight plans mean range PTV coveraged90 (per fraction) 8.5Gy 7.8 9.5Gy Conformity index (D90) 1.8 1.3 2.3 Conformity Index (6Gy) 4.4 2.85 6.0 Homogeneity Dmax/D90) 1.6 1.4 2.0 IMAT static arc (10mm leaf) four plans mean range PTV coveraged90 (per fraction) 7.9 7.5 8.4 Conformity index (D90) 1.9 1.5 2.3 Conformity Index (6Gy) 3.5 2.8 3.9 Homogeneity Dmax/D90) 1.4 1.3 1.45 Conclusion Pre-treatment dosimetric verifications confirm the reliability of the considered treatment planning and delivery systems. Treatment efficacy is strongly dependent on the possibility of daily image guidance and on-line corrections, as confirmed by the analysis of the set-up errors. PTV coverage is dictated by the cord tolerance dose and is higher for IMRT than for IMAT plans, while both the conformity index and the homogeneity ratio are better for IMAT. Conformity is partially lost when using the static MLC. The large number of MUs required for IMRT treatments could be a problem in hypofractionated courses.

Fighting serious disease North America, Atlanta, GA Tel +1 770 300 9725 Fax +1 770 448 6338 info.america@elekta.com Corporate Head Office, Stockholm, Sweden Tel +46 8 587 254 00 Fax +46 8 587 255 00 info@elekta.com Regional Head Offices for Sales, Marketing & Service Europe, South & Central America, Japan, Africa, Middle East & India Kobe Tel +44 1293 654068 Tel +81 78 241 7100 Fax +44 1293 654655 Fax +81 78 271 7823 info.europe@elekta.com info.japan@elekta.com China, Beijing Tel +86 10 8012 5012 Fax +86 10 8012 5000 info.china@elekta.com www.elekta.com Asia-Pacific, Hong Kong, SAR China Tel +852 2891 2208 Fax +852 2575 7133 info.asia@elekta.com Document No. 4513 371 0720 09:07 2007 Elekta Ltd. (publ). All mentioned trademarks and registered trademarks are the property of the Elekta Agroup. All rights reserved. No part of this document may be reproduced in any form without written permission from the copyright holder. Specifications subject to change without notice.